Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicity
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,Hematology
Reference19 articles.
1. Non-Small Cell Lung Cancer, Version 5.2020. NCCN Clinical Practice Guidelines in Oncology 2020 [cited 2020 5/30/2020]; Available from: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.
2. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial;Ball;Lancet Oncol,2019
3. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer;Timmerman;J Clin Oncol,2006
4. Long-term clinical outcomes and safety profile of SBRT for centrally located NSCLC;Arnett;Adv Radiat Oncol,2019
5. Haseltine JM, et al., Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree. Practical radiation oncology, 2016. 6(2): e27–33.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review;International Journal of Radiation Oncology*Biology*Physics;2024-10
2. Safety and Efficacy of Moderate-Intensity Stereotactic Body Radiation Therapy for Ultra-Central Lung Tumor;Medicina;2024-03-26
3. Accelerated Hypofractionated Magnetic Resonance Guided Adaptive Radiation Therapy for Ultracentral Lung Tumors;Tomography;2024-01-17
4. Stereotactic Body Radiation Therapy: Lung Cancers;Fundamentals of Radiation Oncology;2024
5. Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors;International Journal of Radiation Oncology*Biology*Physics;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3